Research Partner

Ovarian Cancer Australia is pleased to support the Australian Ovarian Cancer Study (AOCS), a national collaborative research program between clinicians, scientists, patients and advocacy groups aimed at improving the prevention, diagnosis and treatment of ovarian cancer.

Our partnership agreement allows Ovarian Cancer Australia to transfer any monies donated by third parties to Ovarian Cancer Australia for the express purpose of research into ovarian cancer to AOCS. The OCA-AOCS partnership was initiated to improve outcomes for women with ovarian cancer through patient advocacy and research.

AOCS has supported over 60 projects in Australia, US, UK, Canada and Norway. With major insights into lifestyle, environmental and genetic risk factors for ovarian cancer, and the molecular genetic changes in ovarian cancer cells, AOCS has developed a prominent international reputation.

Initiated in 2001, by Professor David Bowtell at the Peter MacCallum Cancer Centre, and his colleagues at the Queensland Institute of Medical Research, Westmead Institute for Cancer Research, and University of Melbourne, AOCS is a uniquely powerful resource comprised of bio-specimens, clinical and epidemiological data.

AOCS is a major contributor to OCAC, a worldwide study to identify new genes associated ovarian cancer risk, and ICGC, an international consortium to map the cancer genome. AOCS has been made possible through the collaborative spirit of clinicians, nurses, pathologists and scientists throughout Australia and the willingness of thousands of women who participate in this vital program.

For more information about AOCS please visit www.aocstudy.org